Growth Metrics

Opko Health (OPK) Cash from Financing Activities (2016 - 2025)

Opko Health's Cash from Financing Activities history spans 16 years, with the latest figure at -$18.3 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities changed N/A year-over-year to -$18.3 million; the TTM value through Dec 2025 reached -$118.1 million, changed N/A, while the annual FY2025 figure was -$118.1 million, 164.1% down from the prior year.
  • Cash from Financing Activities reached -$18.3 million in Q4 2025 per OPK's latest filing, down from -$16.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $224.6 million in Q3 2024 to a low of -$79.5 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is $7.7 million, with a median of $264000.0 recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: soared 10571.64% in 2024, then plummeted 529.72% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $833000.0 in 2021, then surged by 1117.77% to $10.1 million in 2022, then plummeted by 136.98% to -$3.8 million in 2023, then surged by 6088.75% to $224.6 million in 2024, then plummeted by 108.16% to -$18.3 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Cash from Financing Activities are -$18.3 million (Q4 2025), -$16.2 million (Q3 2025), and -$79.5 million (Q2 2025).